The largest database of trusted experimental protocols

Uplc ms

Manufactured by Waters Corporation
Sourced in United States

The UPLC-MS (Ultra-Performance Liquid Chromatography-Mass Spectrometry) is an analytical instrument that combines the power of ultra-high-performance liquid chromatography (UPLC) with the sensitivity and selectivity of mass spectrometry (MS). It is designed to separate, identify, and quantify a wide range of analytes in complex samples with high resolution and speed.

Automatically generated - may contain errors

45 protocols using uplc ms

1

Glycerophospholipid Profiling by UPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analysis of glycerophospholipid mixtures was carried out utilizing ultra-high-performance liquid chromatography–tandem mass spectrometry (UPLC-MS) (Waters, USA) and a CORTECS UPLC hydrophilic interaction liquid chromatography (HILIC) column (2.1 by 150 mm; inner diameter, 1.6 μm) with the gradient elution at 45°C and a rate of infusion of 0.3 ml · min−1. The mobile-phase gradient was formed by buffer A (acetonitrile) and buffer B (11 mM ammonium acetate). The A/B ratios were 95:5, 95:5, 70:30, 60:40, and 95:5 at run times of 0, 2, 15, 17, and 17.10 min, respectively. The capillary voltage was set at +3.5 kV or −3.5 kV for the positive or negative mode, respectively. Data analysis was based on the following commercial standards at a concentration of 1 mg · liter−1: 16:0 PA (830855; Avanti Polar Lipids), 16:0 PC (850355; Avanti Polar Lipids), 16:0 PS (840037; Avanti Polar Lipids), 16:0 PG (840455; Avanti Polar Lipids), 16:0 PE (850705; Avanti Polar Lipids), and 16:0 PI (850141; Avanti Polar Lipids). The mass amounts of glycerophospholipid were calculated by the following equation: content of glycerophospholipid = a1c0v/a0m, where a1 is the peak area of the sample, a0 is the peak area of the standard, c0 is the concentration of the standard, v is the total volume of the sample, and m is the mass of freeze-dried cells.
+ Open protocol
+ Expand
2

Solubility Determination in PBS with DMSO

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 15

Solubility was determined in phosphate buffered saline (PBS) pH 7.4 with 1% DMSO. Each compound was prepared in duplicate at 100 μM in both 100% DMSO and PBS with 1% DMSO. Compounds were allowed to equilibrate at room temperature with a 250 rpm orbital shake for 24 hours. After equilibration, samples were analyzed by UPLC-MS (Waters, Milford, Mass.) with compounds detected by SIR detection on a single quadrupole mass spectrometer. The DMSO samples were used to create a two point calibration curve to which the response in PBS was fit.

+ Open protocol
+ Expand
3

Stability Determination of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 17

Stability was determined in the presence of PBS pH 7.4 μM and 50 μM glutathione with 0.1% DMSO. Each compound was prepared in duplicate on six separate plates and allowed to equilibrate at room temperature with a 250 rpm orbital shake for 48 hours. One plate was removed at each time point (0, 2, 4, 8, 24, and 48 hours). An aliquot was removed from each well and analyzed by UPLC-MS (Waters, Milford, Mass.) with compounds detected by SIR detection on a single quadrupole mass spectrometer. Additionally, to the remaining material at each time point, acetonitrile was added to force dissolution of compound (to test for recovery of compound). An aliquot of this was also analyzed by UPLC-MS.

+ Open protocol
+ Expand
4

Plasma Stability Determination Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 19

Plasma stability was determined at 37° C. at 5 hours in both human and mouse plasma. Each compound was prepared in duplicate at 5 μM in plasma diluted 50/50 (v/v) with PBS pH 7.4 (0.95% acetonitrile, 0.05% DMSO). Compounds were incubated at 37° C. for 5 hours with a 250 rpm orbital shake with time points taken at 0 and 5 hours. Samples were analyzed by UPLC-MS (Waters, Milford, Mass.) with compounds detected by SIR detection on a single quadrupole mass spectrometer.

+ Open protocol
+ Expand
5

Plasma Protein Binding Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 18

Plasma protein binding was determined by equilibrium dialysis using the Rapid Equilibrium Dialysis (RED) device (Pierce Biotechnology, Rockford, Ill.) for both human and mouse plasma. Each compound was prepared in duplicate at 5 μM in plasma (0.95% acetonitrile, 0.05% DMSO) and added to one side of the membrane (200 μl) with PBS pH 7.4 added to the other side (350 μl). Compounds were incubated at 37° C. for 5 hours with a 250 rpm orbital shake. After incubation, samples were analyzed by UPLC-MS (Waters, Milford, Mass.) with compounds detected by SIR detection on a single quadrupole mass spectrometer.

+ Open protocol
+ Expand
6

In Vitro Metabolism Assay for Mouse Liver Microsomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The assay was performed with mouse liver microsomes from male CD-1. Incubations were performed in duplicates as follows: microsomes in 0.1 M potassium phosphate buffer pH 7.4 (0.8 mg/mL microsomal protein), tested compound (final concentration 20 μM, cosolvent methanol, final concentration 0.38%) were preincubated at 37 °C for 15 min. Metabolic reactions were initiated by the addition of the NADPH regenerating system, containing NADP, glucose-6-phosphate, and glucose-6-phosphate dehydrogenase. Mixtures were incubated at 37 °C for various time periods (15, 30, 60 min). Enzymatic reactions were quenched by perchloric acid followed by addition of internal standard (pentoxifylline). Negative controls were performed without NADPH-regenerating system. After centrifugation, samples were analyzed by LC/MS (UPLC/MS, Waters Corporation, Milford, MA, USA). In vitro half time (t1/2) and intrinsic clearance (Clint) of test compound in liver microsomes were determined according to literature procedures [26 (link),63 (link)].
+ Open protocol
+ Expand
7

Quantitative UPLC-MS Analysis of Hepatic Bile Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
An ultra-performance liquid chromatography instrument coupled with a quatropole mass spectrometry (UPLC-MS, Waters Co., MA, USA) was used to detect hepatic bile acids. Livers were homogenized in acetonitrile (100 mg tissue/500 μl acetonitrile) followed by centrifugation at 14,300 rpm for 10 min. The supernatant was dried under nitrogen steam, then re-dissolved in methanol solution (methanol : water : formic acid = 50 : 50 : 0.01) followed by centrifugation at 14,300 rpm for 10 min. The supernatants were injected into the UPLC-MS instrument. Both the UPLC and MS parameters were described in our previous publication [29 (link)]. Bile acids profiles in control and RA-treated mice were differentiated by principle component analysis (PCA). Significance of differences between individual bile acid levels in control and all-trans RA-treated mice were examined by Student's t-test.
+ Open protocol
+ Expand
8

In Vitro ADME Profiling of Novel Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse liver microsomes (MLMs) were used to investigate the phase I metabolism of selected compounds (2c, 2d, 3b, 4g, 5a) and the reference substance BP-2. Samples composed of test compound (20 µM), MLMs (0.8 mg/mL) and potassium phosphate buffer (100 mM, pH 7.4) were preincubated prior to addition of NADPH-regenerating system. NADPH-regenerating system contained NADP, glucose-6-phosphate, glucose-6-phosphate dehydrogenase and potassium phosphate buffer (100 mM, pH 7.4). Control incubations were performed in the absence of the NADPH-regenerating system [73 (link)] and in case of esters (2c, 2d, 3b and 4g) without the mouse liver microsomes solution to determine spontaneous hydrolysis [59 (link)]. Incubations were conducted at 37 °C for at least 15 min up to 60 min. The reactions were stopped by the addition of 250 μL ice-cold methanol containing internal standard PTX (20 μM). The mixture was then centrifuged. Supernatant analysis was performed using UPLC/MS (Waters Corporation). The assays were repeated two times. The in vitro half times (t1/2) for test compounds were determined from the slope of the linear regression of ln % parent compound remaining versus incubation time. The calculated t1/2 was incorporated into the following equation to obtain intrinsic clearance: (Clint) = (volume of incubation [µL]/ protein in the incubation [mg]) × 0.693 / t1/2 [74 (link)].
+ Open protocol
+ Expand
9

Quantification of Hepatic Bile Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
An ultra-performance liquid chromatography instrument coupled with a quatropole mass spectrometry (UPLC-MS, Waters Co., MA, USA) was used to detect hepatic bile acids. Livers were homogenized in acetonitrile (100 mg tissue/500 μl acetonitrile) followed by centrifugation at 14,300 rpm for 10 min. The supernatant was blown to dryness under nitrogen stream, then re-dissolved in methanol-water solution (methanol:water:formic acid = 50:50:0.01) followed by centrifugation at 14,300 rpm for 10 min. Samples of 5 μl of the supernatants were injected into the UPLC-MS instrument. The instrument parameters were applied based on previous study47 (link).
+ Open protocol
+ Expand
10

Anthocyanin Extraction from Grape Skin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Extraction method of anthocyanins from grape berry skin was referred to He et al. [7 (link)] and Sun et al. [61 (link), 62 (link)]. The UPLC-MS (Waters, Milford, MA, USA) was used to determine the composition and contents of anthocyanins, and the method was referred to Sun et al. [61 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!